Mucolytics in acute and chronic respiratory tract disorders. Part I. Patophysiology mechanisms of action;Mukolityki w ostrych i przewlekłych chorobach dróg oddechowych. Czȩść I. Patofizjologia i mechanizmy działania

Polski Merkuriusz Lekarski

Volumn 12, Issue 69, 2002, Pages 245-247

  Kupczyk, Maciej ^a   Kuna, Piotr ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Ambroxol; Chronic disorders; Mucolytics; N acetylcysteine; Respiratory tract; Therapy of respiratory tract disorders

Indexed keywords

ACETYLCYSTEINE; AMBROXOL; MUCOLYTIC AGENT;

ACUTE DISEASE; AIRWAY OBSTRUCTION; ARTICLE; BACTERIAL COLONIZATION; CHRONIC DISEASE; DRUG INDICATION; DRUG MECHANISM; HUMAN; LUNG FUNCTION; MUCOCILIARY CLEARANCE; MUCUS SECRETION; PATHOPHYSIOLOGY; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE;

ACETYLCYSTEINE; ACUTE DISEASE; AMBROXOL; CHRONIC DISEASE; EXPECTORANTS; HUMANS; RESPIRATORY TRACT DISEASES;

EID: 18244416384     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Acetaminophen poisoning
2. The use of mucolytic preparations (Mucosolvan) in nasal and paranasal sinuses in children
3. Mucus transport and phtysiotherapy - A new series
4. Effect of drugs on mucus clearance
5. Regulation of mucociliary clearamce in health disease
6. Mucin gene expression in rat airways following infection and irritation
7. Airway mucosa, secretory cells, mucus and mucin genes
8. Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning, a critical review
9. Clinical applications of N-acetylcysteine
10. Airway goblet cell mucin: Its structure regulation of secretion
11. Airway mucus
12. Lung mucus, a clinician's view
13. Atenatal use of ambroxol for the prevention of infant respiratory distress syndrome
14. Airway epithelium as an effector of inflammation molecular regulation of secondary mediators
15. A pharmacocinetic study on pulmonary tropism of ambroxol in patients under thoracic surgery
16. Role of neutrophil elastase in hypersecretion during COPD exacerbations, and proposed therapies
17. P2Y receptor agonists
18. Chronic mucus hypersecretion in COPD and death from pulmonary infection
19. Mucus hypersecretion in chronic obstructive pulmonary disease
20. Neutrophil elastase inhibitors
21. Regulation of depth composition of airway surface liquid